Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Keogh

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Australian Prescriber|June 28, 2016
Switching and stopping antidepressantsNicholas Keks, Judy Hope, Simone Keogh
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 11, 2017
Suvorexant: scientifically interesting, utility uncertainNicholas A Keks, Judy Hope, Simone Keogh
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|September 11, 2018
Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressantNicholas A Keks, Judy Hope, Simone Keogh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Australian Prescriber|June 28, 2016
Switching and stopping antidepressantsNicholas Keks, Judy Hope, Simone Keogh
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 11, 2017
Suvorexant: scientifically interesting, utility uncertainNicholas A Keks, Judy Hope, Simone Keogh
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|September 11, 2018
Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressantNicholas A Keks, Judy Hope, Simone Keogh, et al.
Pageof 1